Skip to main content
. 2014 Dec 24;9(3):1373–1379. doi: 10.3892/ol.2014.2830

Figure 1.

Figure 1

Alteration of CEA level and treatment at different time-points. The patient first presented with a raised CEA level. The CEA level gradually decreased to 5.9 ng/ml (normal value, 0–5 ng/ml) following 3 months of erlotinib treatment. CEA, carcinoembryonic antigen.